Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3720563 | 0.83 | ALDH1A1 (0.48) | ALDH1A1TDP1KMT2APARP10MAPT | |
| SCHEMBL1052924 | 0.83 | ALDH1A1 (0.52) | ALDH1A1KMT2APARP10KDM4EPOLB | |
| SCHEMBL339527 | 0.83 | ALDH1A1 (0.52) | ALDH1A1KMT2APARP10MAPTHPGD | |
| SCHEMBL15599154 | 0.81 | TDP1 (0.74) | TRPA1PTGS1CACNA1CALDH1A1TDP1 | |
| SCHEMBL13220460 | 0.81 | TDP1 (0.54) | TRPA1PTGS1CACNA1CALDH1A1TDP1 | |
| SCHEMBL10153872 | 0.80 | TDP1 (0.62) | ALDH1A1TDP1KMT2APARP10MAPT | |
| SCHEMBL4962026 | 0.79 | ALDH1A1 (0.48) | ALDH1A1KMT2APARP10HPGDPOLB | |
| SCHEMBL13211785 | 0.78 | ALDH2 (0.55) | TRPA1PTGS1CACNA1CALDH1A1TDP1 | |
| SCHEMBL78097 | 0.78 | TSHR (0.50) | TRPA1PTGS1CACNA1CALDH1A1KMT2A | |
| SCHEMBL8208073 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KMT2APARP10HPGDPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118666647-A | Green co-production method of benzoquinone compound and hydroquinone | 浙江大学 | 2024-09-20 | — | — | CN | claimed |
| CN-118666647-A | Green co-production method of benzoquinone compound and hydroquinone | 浙江大学 | 2024-09-20 | — | — | CN | disclosed |
| EP-3468541-B1 | ANTIPROTOZOAL AGENTS | UNIV KIEL CHRISTIAN ALBRECHTS (DE) | 2021-09-22 | — | — | EP | disclosed |
| WO-2017211988-A1 | ACTIVE AGENTS AGAINST PROTOZOA | CHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL (DE) | 2017-12-14 | — | — | WO | disclosed |
| US-20090209522-A1 | Heterocyclic Non-Peptide GNRH Antagonists | TAKEDA CAMBRIDGE LIMITED (GB) | 2009-08-20 | — | — | US | disclosed |
| EP-1896465-A1 | HETEROCYCLIC NON-PEPTIDE GNRH ANTAGONISTS | Takeda Cambridge Limited (GB) | 2008-03-12 | — | — | EP | disclosed |
| WO-2007000582-A1 | HETEROCYCLIC NON-PEPTIDE GNRH ANTAGONISTS | TAKEDA CAMBRIDGE LIMITED (GB) | 2007-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209522-A1 | Heterocyclic Non-Peptide GNRH Antagonists | GNRHR, GHRHR, FSHR | TRPA1 3428/4885PTGS1 2635/4885CACNA1C 3084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.